tiprankstipranks
Core Laboratories N.V. (CLB)
NYSE:CLB
US Market
Want to see CLB full AI Analyst Report?

Core Laboratories (CLB) Ratios

223 Followers

Core Laboratories Ratios

CLB's free cash flow for Q1 2026 was $0.16. For the 2026 fiscal year, CLB's free cash flow was decreased by $ and operating cash flow was $0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.05 2.02 2.32 2.53 2.05
Quick Ratio
1.50 1.51 1.71 1.72 1.47
Cash Ratio
0.22 0.21 0.20 0.17 0.15
Solvency Ratio
0.15 0.14 0.14 0.15 0.09
Operating Cash Flow Ratio
0.34 0.35 0.58 0.28 0.24
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -98.21M$ -97.14M$ -106.06M$ -133.45M$ -177.70M
Leverage Ratios
Debt-to-Assets Ratio
0.29 0.28 0.31 0.37 0.38
Debt-to-Equity Ratio
0.62 0.62 0.71 0.96 1.21
Debt-to-Capital Ratio
0.38 0.38 0.42 0.49 0.55
Long-Term Debt-to-Capital Ratio
0.30 0.29 0.33 0.42 0.48
Financial Leverage Ratio
2.19 2.20 2.34 2.61 3.14
Debt Service Coverage Ratio
5.42 5.26 4.81 4.93 4.18
Interest Coverage Ratio
4.99 4.78 4.73 4.07 3.59
Debt to Market Cap
0.23 0.15 0.16 0.20 0.18
Interest Debt Per Share
3.88 3.75 4.11 4.90 5.05
Net Debt to EBITDA
2.00 1.99 2.19 2.84 3.53
Profitability Margins
Gross Profit Margin
17.84%17.91%16.87%18.45%16.11%
EBIT Margin
10.28%10.72%11.18%10.72%8.48%
EBITDA Margin
13.79%13.51%14.03%13.81%11.98%
Operating Profit Margin
10.33%9.59%11.18%10.72%8.48%
Pretax Profit Margin
8.21%8.72%8.82%8.08%6.12%
Net Profit Margin
5.53%5.63%5.99%7.19%3.97%
Continuous Operations Profit Margin
5.64%5.77%6.14%7.26%4.01%
Net Income Per EBT
67.40%64.64%67.98%89.00%64.94%
EBT Per EBIT
79.51%90.90%78.88%75.42%72.14%
Return on Assets (ROA)
4.94%5.08%5.32%6.25%3.36%
Return on Equity (ROE)
10.74%11.15%12.46%16.31%10.56%
Return on Capital Employed (ROCE)
11.22%10.56%11.88%10.97%8.74%
Return on Invested Capital (ROIC)
7.51%6.83%8.10%9.65%5.60%
Return on Tangible Assets
6.11%6.30%6.48%7.64%4.13%
Earnings Yield
5.51%3.98%3.87%4.45%2.07%
Efficiency Ratios
Receivables Turnover
4.56 4.36 4.11 4.14 4.25
Payables Turnover
10.78 11.60 12.60 12.41 8.96
Inventory Turnover
7.46 7.93 7.33 5.80 6.80
Fixed Asset Turnover
3.15 3.42 3.41 3.32 3.11
Asset Turnover
0.89 0.90 0.89 0.87 0.85
Working Capital Turnover Ratio
4.81 4.43 3.97 4.19 4.74
Cash Conversion Cycle
95.20 98.28 109.57 121.65 98.76
Days of Sales Outstanding
80.13 83.74 88.74 88.11 85.79
Days of Inventory Outstanding
48.92 46.02 49.79 62.95 53.70
Days of Payables Outstanding
33.85 31.48 28.96 29.42 40.73
Operating Cycle
129.05 129.76 138.53 151.07 139.49
Cash Flow Ratios
Operating Cash Flow Per Share
0.76 0.80 1.20 0.53 0.54
Free Cash Flow Per Share
0.41 0.49 0.92 0.30 0.32
CapEx Per Share
0.35 0.31 0.28 0.23 0.22
Free Cash Flow to Operating Cash Flow
0.54 0.61 0.77 0.57 0.59
Dividend Paid and CapEx Coverage Ratio
1.94 2.26 3.78 1.99 2.07
Capital Expenditure Coverage Ratio
2.17 2.55 4.33 2.34 2.44
Operating Cash Flow Coverage Ratio
0.21 0.23 0.31 0.12 0.11
Operating Cash Flow to Sales Ratio
0.07 0.07 0.11 0.05 0.05
Free Cash Flow Yield
3.59%3.03%5.34%1.72%1.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.80 23.57 25.84 22.48 48.28
Price-to-Sales (P/S) Ratio
0.96 1.42 1.55 1.62 1.92
Price-to-Book (P/B) Ratio
1.87 2.80 3.22 3.67 5.10
Price-to-Free Cash Flow (P/FCF) Ratio
26.58 33.00 18.72 58.02 63.72
Price-to-Operating Cash Flow Ratio
14.33 20.05 14.40 33.26 37.63
Price-to-Earnings Growth (PEG) Ratio
2.02 15.79 -1.70 0.26 -20.76
Price-to-Fair Value
1.87 2.80 3.22 3.67 5.10
Enterprise Value Multiple
8.96 12.47 13.23 14.55 19.53
Enterprise Value
671.91M 886.71M 972.77M 1.02B 1.15B
EV to EBITDA
9.29 12.47 13.23 14.55 19.53
EV to Sales
1.28 1.68 1.86 2.01 2.34
EV to Free Cash Flow
35.48 39.26 22.43 72.11 77.76
EV to Operating Cash Flow
19.14 23.85 17.25 41.34 45.93
Tangible Book Value Per Share
3.53 3.43 3.24 2.64 1.77
Shareholders’ Equity Per Share
5.84 5.72 5.37 4.82 3.98
Tax and Other Ratios
Effective Tax Rate
0.31 0.34 0.30 0.10 0.34
Revenue Per Share
11.39 11.32 11.17 10.92 10.57
Net Income Per Share
0.63 0.64 0.67 0.79 0.42
Tax Burden
0.67 0.65 0.68 0.89 0.65
Interest Burden
0.80 0.81 0.79 0.75 0.72
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.09 0.08 0.07 0.08 0.08
Stock-Based Compensation to Revenue
0.01 0.01 <0.01 0.03 0.02
Income Quality
1.11 1.17 1.75 0.67 1.27
Currency in USD